This page shows Nano Mobile Healthcare Inc (VNTH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Liquidity strain rather than operating scale defines this business, as obligations overwhelm a shrinking asset base.
Across the last three reported years, current resources thinned faster than liabilities: cash fell from$235K to$60K . At the same time, the current ratio slid from 0.4x to 0.04x, showing that each step down in liquidity left the company less able to meet near-term claims from liquid assets.
By the latest year, liabilities of
Overhead still outran liquidity in the latest year, with SG&A at
Financial Health Signals
We are recalculating Nano Mobile Healthcare Inc's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
Key Financial Metrics
Earnings & Revenue
Nano Mobile Healthcare Inc earned $-0.10 per diluted share (EPS) in fiscal year 2016. This represents a decrease of 266.7% from the prior year.
Cash & Balance Sheet
Nano Mobile Healthcare Inc held $60K in cash against $0 in long-term debt as of fiscal year 2016.
Nano Mobile Healthcare Inc had 49M shares outstanding in fiscal year 2016. This represents an increase of 115.8% from the prior year.
Margins & Returns
Capital Allocation
VNTH Income Statement
| Metric | Q1'17 | Q4'16 | Q3'16 | Q2'16 | Q1'16 | Q4'15 | Q3'15 | Q2'15 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | $101K+88.7% | $53K-47.7% | $102K | N/A | $105K-34.3% | $160K |
| Operating Income | N/A | N/A | -$195K | N/A | -$462K | N/A | N/A | -$552K |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | -$179K+24.9% | -$238K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A | $407K | N/A | N/A | N/A |
| EPS (Diluted) | $0.00 | N/A | N/A | N/A | $0.00 | N/A | N/A | N/A |
VNTH Balance Sheet
| Metric | Q1'17 | Q4'16 | Q3'16 | Q2'16 | Q1'16 | Q4'15 | Q3'15 | Q2'15 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $405-99.6% | $104K+52.3% | $68K-9.6% | $75K-27.4% | $104K-65.7% | $303K+229.7% | $92K-30.3% | $132K |
| Current Assets | N/A | $93K+59.6% | $58K-10.4% | $65K-30.0% | $93K-68.0% | $292K+262.3% | $81K-32.9% | $120K |
| Cash & Equivalents | N/A | $60K+20.2% | $50K+51.5% | $33K-45.1% | $60K-76.0% | $250K+257.3% | $70K-30.2% | $100K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $6.6M+154.2% | $2.6M-78.3% | $12.0M+63.4% | $7.3M+182.0% | $2.6M-31.0% | $3.8M+117.6% | $1.7M+22.0% | $1.4M |
| Current Liabilities | $6.6M+154.2% | $2.6M-78.1% | $11.9M+64.4% | $7.2M+202.0% | $2.4M-33.7% | $3.6M+136.2% | $1.5M+37.0% | $1.1M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$6.6M-164.8% | -$2.5M+79.1% | -$11.9M-64.2% | -$7.3M-190.7% | -$2.5M+27.9% | -$3.5M-111.3% | -$1.6M-27.4% | -$1.3M |
| Retained Earnings | -$12.0M-83.2% | -$6.6M+60.8% | -$16.8M-43.8% | -$11.7M-77.6% | -$6.6M+5.8% | -$7.0M+36.8% | -$11.0M-12.0% | -$9.9M |
VNTH Cash Flow Statement
| Metric | Q1'17 | Q4'16 | Q3'16 | Q2'16 | Q1'16 | Q4'15 | Q3'15 | Q2'15 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | -$435K-70.1% | -$256K | N/A | -$508K-91.0% | -$266K | N/A | -$445K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | $0 | $0 | $0 |
| Financing Cash Flow | N/A | $385K+41.1% | $273K-25.8% | $367K+15.3% | $318K-28.6% | $446K | N/A | $445K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
VNTH Financial Ratios
| Metric | Q1'17 | Q4'16 | Q3'16 | Q2'16 | Q1'16 | Q4'15 | Q3'15 | Q2'15 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | 392.2% | N/A | N/A | N/A |
| Current Ratio | N/A | 0.04+0.0 | 0.000.0 | 0.01-0.0 | 0.04-0.0 | 0.08+0.0 | 0.05-0.1 | 0.11 |
| Debt-to-Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$2.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.04), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What are Nano Mobile Healthcare Inc's total assets?
Nano Mobile Healthcare Inc (VNTH) had $104K in total assets as of fiscal year 2016, including both current and long-term assets.
What is Nano Mobile Healthcare Inc's current ratio?
Nano Mobile Healthcare Inc (VNTH) had a current ratio of 0.04 as of fiscal year 2016, which is below 1.0, which may suggest potential liquidity concerns.
Why is Nano Mobile Healthcare Inc's debt-to-equity ratio negative or not reported?
Nano Mobile Healthcare Inc (VNTH) has negative shareholder equity of -$2.5M as of fiscal year 2016, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.